Buddhadev Layek

3.1k total citations · 2 hit papers
41 papers, 2.1k citations indexed

About

Buddhadev Layek is a scholar working on Molecular Biology, Biomaterials and Genetics. According to data from OpenAlex, Buddhadev Layek has authored 41 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 11 papers in Biomaterials and 8 papers in Genetics. Recurrent topics in Buddhadev Layek's work include RNA Interference and Gene Delivery (18 papers), Advanced biosensing and bioanalysis techniques (9 papers) and Virus-based gene therapy research (8 papers). Buddhadev Layek is often cited by papers focused on RNA Interference and Gene Delivery (18 papers), Advanced biosensing and bioanalysis techniques (9 papers) and Virus-based gene therapy research (8 papers). Buddhadev Layek collaborates with scholars based in United States and India. Buddhadev Layek's co-authors include Jagdish Singh, Swayam Prabha, Richard Nii Lante Lamptey, Avinash Gothwal, Bivek Chaulagain, Riddhi Trivedi, Sanchita Mandal, Tanmoy Sadhukha, Sanjay Arora and Anurag Banerjee and has published in prestigious journals such as Biomaterials, International Journal of Molecular Sciences and Journal of Controlled Release.

In The Last Decade

Buddhadev Layek

39 papers receiving 2.0k citations

Hit Papers

A Review of the Common Neurodegenerative Disorders: Curre... 2022 2026 2023 2024 2022 2024 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Buddhadev Layek United States 25 966 526 360 247 198 41 2.1k
Saurabh Srivastava India 31 1.1k 1.2× 539 1.0× 390 1.1× 309 1.3× 157 0.8× 149 2.6k
Yubo Guo China 30 1.6k 1.7× 800 1.5× 537 1.5× 134 0.5× 162 0.8× 53 2.7k
Surajit Karmakar India 31 993 1.0× 552 1.0× 516 1.4× 227 0.9× 106 0.5× 84 2.5k
Mingji Jin China 29 1.5k 1.6× 778 1.5× 615 1.7× 267 1.1× 168 0.8× 106 3.0k
Xiyang Sun China 20 831 0.9× 582 1.1× 653 1.8× 242 1.0× 89 0.4× 32 2.0k
Wei Shao China 23 1.3k 1.3× 291 0.6× 342 0.9× 81 0.3× 158 0.8× 58 2.4k
Dharmendra Kumar Khatri India 31 1.1k 1.1× 302 0.6× 258 0.7× 286 1.2× 304 1.5× 133 2.6k
Daniela Belletti Italy 21 627 0.6× 663 1.3× 377 1.0× 306 1.2× 274 1.4× 56 1.7k
Young Tag Ko South Korea 33 1.3k 1.3× 932 1.8× 1.0k 2.8× 425 1.7× 99 0.5× 74 2.9k

Countries citing papers authored by Buddhadev Layek

Since Specialization
Citations

This map shows the geographic impact of Buddhadev Layek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Buddhadev Layek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Buddhadev Layek more than expected).

Fields of papers citing papers by Buddhadev Layek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Buddhadev Layek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Buddhadev Layek. The network helps show where Buddhadev Layek may publish in the future.

Co-authorship network of co-authors of Buddhadev Layek

This figure shows the co-authorship network connecting the top 25 collaborators of Buddhadev Layek. A scholar is included among the top collaborators of Buddhadev Layek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Buddhadev Layek. Buddhadev Layek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Layek, Buddhadev, et al.. (2026). Mesenchymal Stem Cell Exosome-Mediated Delivery of Paclitaxel for Pancreatic Cancer Therapy. Biomolecules. 16(2). 269–269.
2.
Layek, Buddhadev, et al.. (2025). Advanced intranasal peptide delivery systems for improved management of Alzheimer's disease. Biomaterials Advances. 178. 214474–214474. 1 indexed citations
3.
Banerjee, Anurag, et al.. (2024). Neuroinflammation in Neurodegenerative Disorders: Current Knowledge and Therapeutic Implications. International Journal of Molecular Sciences. 25(7). 3995–3995. 56 indexed citations breakdown →
4.
Layek, Buddhadev. (2024). A Comprehensive Review of Xanthan Gum-Based Oral Drug Delivery Systems. International Journal of Molecular Sciences. 25(18). 10143–10143. 17 indexed citations
5.
Banerjee, Anurag, et al.. (2024). Mesenchymal stem cell-delivered paclitaxel nanoparticles exhibit enhanced efficacy against a syngeneic orthotopic mouse model of pancreatic cancer. International Journal of Pharmaceutics. 666. 124753–124753.
6.
Sathish, Venkatachalem, et al.. (2024). Nanocarrier mediated entinostat and oxaliplatin combination therapy displayed enhanced efficacy against pancreatic cancer. Biomedicine & Pharmacotherapy. 175. 116743–116743. 3 indexed citations
7.
Lamptey, Richard Nii Lante, Chengwen Sun, Buddhadev Layek, & Jagdish Singh. (2023). Neurogenic Hypertension, the Blood–Brain Barrier, and the Potential Role of Targeted Nanotherapeutics. International Journal of Molecular Sciences. 24(3). 2213–2213. 8 indexed citations
8.
Layek, Buddhadev, Bina Gidwani, Sakshi Tiwari, et al.. (2020). Recent Advances in Lipid-based Nanodrug Delivery Systems in Cancer Therapy. Current Pharmaceutical Design. 26(27). 3218–3233. 24 indexed citations
9.
Layek, Buddhadev, Tanmoy Sadhukha, Jayanth Panyam, & Swayam Prabha. (2018). Nano-Engineered Mesenchymal Stem Cells Increase Therapeutic Efficacy of Anticancer Drug Through True Active Tumor Targeting. Molecular Cancer Therapeutics. 17(6). 1196–1206. 88 indexed citations
10.
Sadhukha, Tanmoy, Buddhadev Layek, & Swayam Prabha. (2017). Incorporation of lipolysis in monolayer permeability studies of lipid-based oral drug delivery systems. Drug Delivery and Translational Research. 8(2). 375–386. 24 indexed citations
11.
Layek, Buddhadev, Tanmoy Sadhukha, & Swayam Prabha. (2016). Glycoengineered mesenchymal stem cells as an enabling platform for two-step targeting of solid tumors. Biomaterials. 88. 97–109. 64 indexed citations
12.
Layek, Buddhadev, et al.. (2015). APC targeted micelle for enhanced intradermal delivery of hepatitis B DNA vaccine. Journal of Controlled Release. 207. 143–153. 50 indexed citations
13.
Nahire, Rahul, Manas K. Haldar, Shirshendu Paul, et al.. (2014). Multifunctional polymersomes for cytosolic delivery of gemcitabine and doxorubicin to cancer cells. Biomaterials. 35(24). 6482–6497. 80 indexed citations
14.
Layek, Buddhadev & Jagdish Singh. (2013). Caproic acid grafted chitosan cationic nanocomplexes for enhanced gene delivery: Effect of degree of substitution. International Journal of Pharmaceutics. 447(1-2). 182–191. 31 indexed citations
15.
Layek, Buddhadev & Jagdish Singh. (2012). N-hexanoyl, N-octanoyl and N-decanoyl chitosans: Binding affinity, cell uptake, and transfection. Carbohydrate Polymers. 89(2). 403–410. 26 indexed citations
16.
Layek, Buddhadev. (2010). Tamoxifen Citrate Encapsulated Sustained Release Liposomes: Preparation and Evaluation of Physicochemical Properties. Scientia Pharmaceutica. 78(3). 507–515. 27 indexed citations
20.
Mukherjee, Biswajit, et al.. (2006). Nefopatli containing transdermal-matrix patches: Based on pressure-sensitive adhesive polymers. 30(3). 146–163. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026